Home » Topics » Disease categories and therapies » Cancer

Cancer
RSS

CD-437, a novel retinoid compound targeted to the treatment of leukemia

Feb. 18, 1999

Specific inhibitors of MEK for cancer and other proliferative disorders

Feb. 18, 1999

Zarix in-licenses oncology drug from Agouron

Feb. 18, 1999

Initial findings reported for CollaGenex's anticancer compound

Feb. 17, 1999

Wistar Institute discovers mechanism of action of farnesyltransferase inhibitors

Feb. 17, 1999

First pivotal trial results reported for marimastat; BB to assess implications for development

Feb. 16, 1999

Available for licensing from NIH: BOG gene and protein product for Rx, Dx use

Feb. 15, 1999

U. of Arizona prepares novel cyanoaziridine-based antitumor agents

Feb. 15, 1999

ProScript initiates second phase I trial for PS-341

Feb. 15, 1999

Aronex initiates phase I/II trial of Atragen + interferon alfa in renal cell carcinoma

Feb. 15, 1999

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for June 17, 2026.
News in brief
BioWorld Asia
BioWorld Asia briefs for June 16, 2026
For clonal hematopoiesis, epigenetics can be in driver’s seat
BioWorld Science
Clonal hematopoiesis (CH), where few blood stem cells produce a significant fraction of mature blood cells that are genetically identical, is partly an inevitable...
Elixiron’s enrupatinib shows upbeat interim phase II AD results
BioWorld
Elixiron Immunotherapeutics Inc. announced positive interim open-label phase II Alzheimer’s disease (AD) study findings of enrupatinib, an oral brain-penetrant...
Gene replacement rescues autism-related phenotypes in mice
BioWorld Science
Autism spectrum disorder (ASD), developmental epileptic encephalopathies and other neurodevelopmental disorders are driven by the disruption of genes regulating...